hydroxyl radical has been researched along with anandamide in 1 studies
Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (anandamide) | Trials (anandamide) | Recent Studies (post-2010) (anandamide) |
---|---|---|---|---|---|
10,147 | 26 | 3,657 | 2,566 | 29 | 957 |
Protein | Taxonomy | hydroxyl radical (IC50) | anandamide (IC50) |
---|---|---|---|
Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 3.75 | |
Potassium channel subfamily K member 3 | Homo sapiens (human) | 3 | |
Potassium channel subfamily K member 2 | Bos taurus (cattle) | 1 | |
Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 4.78 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harada, H; Ito, A; Ito, T; Iwata, O; Kameyama, N; Mishima, Y; Ushijima, K; Watanabe, S | 1 |
1 other study(ies) available for hydroxyl radical and anandamide
Article | Year |
---|---|
Propofol protects against anandamide-induced injury in human umbilical vein endothelial cells.
Topics: Amidohydrolases; Anesthetics, Intravenous; Antioxidants; Apoptosis; Arachidonic Acids; Calcium Channel Blockers; Caspase 3; Cell Survival; Dose-Response Relationship, Drug; Endocannabinoids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxyl Radical; Polyunsaturated Alkamides; Propofol; Reactive Oxygen Species; Time Factors; Treatment Outcome; Vascular System Injuries | 2011 |